‹ zurück Sie sind hier:  Startseite » Buchhändler » MARZIES.de Buch- und Medienhan… » Prodrugs and Targeted Delivery Towards Better ADME Properties

Linksbuch Neu neu Rechtsbuch

Rautio, Jarkko (Herausgeber)

Prodrugs and Targeted Delivery Towards Better ADME Properties (Gebundene Ausgabe)

Reihe: Methods and Principles in Medicinal Chemistry 47

Wiley VCH Verlag GmbH, Wiley-VCH Verlag GmbH & Co. KGaA, Dezember 2010

496 S. - Sprache: Englisch - 15 farbige Abbildungen - 250x180x33 mm

ISBN: 3527326030 EAN: 9783527326037

This topical reference and handbook addresses the chemistry, pharmacology, toxicology and the patentability of prodrugs, perfectly mirroring the integrated approach prevalent in today's drug design. It summarizes current experiences and strategies for the rational design of prodrugs, beginning at the early stages of the development process, as well as discussing organ- and site-selective prodrugs. Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development.

Preis: 169,90 EUR
Versandkosten: 0,00 EUR
Gesamtpreis: 169,90 EUR
In den Warenkorb

Anbieter: MARZIES.de Buch- und Medienhan… (Impressum/Lieferzeit)
Katalog: HC/Sprachwissenschaft/Sonstiges

Angebotene Zahlungsarten: Vorauskasse
Transparente Bestellabwicklung - Verkäufer nutzt Order-Control - klicken für mehr Information
Transparente Bestellabwicklung -
Verkäufer nutzt Order-Control



Preface PART ONE: Prodrug Design and Intellectual Property PRODRUG STRATEGIES IN DRUG DESIGN Prodrug Concept Basics of Prodrug Design Rationale for Prodrug Design History of Prodrug Design Recently Marketed Prodrugs Concluding Remarks THE MOLECULAR DESIGN OF PRODRUGS BY FUNCTIONAL GROUP Introduction The Prodrug Concept and Basics of Design Common Functional Group Approaches in Prodrug Design Conclusions INTELLECTUAL PROPERTY PRIMER ON PHRAMACEUTICAL PATENTS WITH A SPECIAL EMPHASIS ON PRODRUGS AND METABOLITES Introduction Patents and FDA Approval Process Obtaining a Patent Conclusion PART TWO: Prodrugs Addressing ADMET Issues INCREADING LIPOPHILICITY FOR ORAL DRUG DELIVERY Introduction pKa, Degree of Ionization, Partition Coefficient, and Distribution Coefficient Prodrug Strategies to Enhance Lipid Solubility Prodrug Examples for Antibiotics Antiviral Related Prodrugs Cardiovascular Related Prodrugs Lipophilic Prodrugs of Benzamidine Drugs Miscellaneous Examples Summary and Conclusion MODULATING SOLUBILITY THROUGH PRODRUGS FOR ORAL AND IV DRUG DELIVERY Introduction Basics of Solubility and Oral/IV Drug Delivery Prodrug Applications for Enhanced Aqueous Solubility Challenges with Solubilizing Prodrugs of Insoluble Drugs Additional Applications of Prodrugs for Modulating Solubility Parallel Exploration of Analogues and Prodrugs in Drug Discovery (Commentary) Conclusions PRODRUGS DESIGNED TO TARGET TRANSPORTERS FOR ORAL DRUG DELIVERY Introduction Serendipity: An Actively Transported Prodrug Requirements for Actively Transported Prodrugs Peptide Transporters: PEPT1 and PEPT2 Monocarboxylate Transporters Bile Acid Transporters Conclusions TOPICAL AND TRANSDERMAL DELIVERY USING PRODRUGS: MECHANISM OF ENHANCEMENT Introduction Arrangement of Water in the Stratum Corneum A New Model for Diffusion Through the Stratum Corneum: The Biphasic Solubility Model Equations for Quantifying Effects of Solubility on Diffusion Through the Stratum Corneum Design of Prodrugs for Topical and Transdermal Delivery Based on the Biphasic Solubility Model Comparison of Human and Mouse Skin Experiments Summary OCULAR DELIVERY USING PRODRUGS Introduction Criteria for an Ideal Ophthalmic Prodrug Anatomy and Physiology of the Eye Barriers to Ocular Drug Delivery Influx and Efflux Transporters on the Eye Transporter-Targeted Prodrug Approach Drug Disposition in Ocular Delivery Effect of Physiochemical Factors on Drug Disposition in Eye Prodrug Strategy to Improve Ocular Bioavailability (Nontransporter-Targeted Approach) Recent Patents and Marketed Ocular Prodrugs Novel Formulation Approaches for Sustained Delivery of Prodrugs Conclusion REDUCING PRESYSTEMIC DRUG METABOLISM Introduction Presystemic Metabolic Barriers Prodrug Approaches to Reduce Presystemic Drug Metabolism Targeting Colon Targeting Lymphatic Route Conclusion ENZYME-ACTIVATED PRODRUG STRATEGIES FOR SITE-SELECTIVE DRUG DELIVERY Introduction General Requirements for Enzyme-Activated Targeted Prodrug Strategy Examples of Targeted Prodrug Strategies Summary PRODRUG APPROACHES FOR CENTRAL NERVOUS SYSTEM DELIVERY Blood-Brain Barrier in CNS Drug Development Prodrug Strategies Prodrug Strategies Based Upon BBB Nutrient Transporters Prodrug Strategies Based Upon BBB Receptors CNS Prodrug Summary DIRECTED ENZYME PRODRUG THERAPIES Introduction Theoretical Background of DEPT Comparison of ADEPT and GDEPT Enzymes in ADEPT and GDEPT Design of Prodrugs Strategies Used for the Improvement of DEPT Systems Biological Data for ADEPT and GDEPT Conclusions PART THREE: Codrugs and Soft Drugs IMPROVING THE USE OF DRUG COMBINATIONS THROUGH THE CODRUG APPROACH Codrugs and Codrug Strategy Ideal Codrug Characteristics Examples of Marketed Codrugs Topical Codrug Therapy for the Treatment of Ophthalmic Diseases Codrugs for Transdermal Delivery Codrugs of L-DOPA for the Treatment of Parkinson's Disease Analgesic Codrugs Containing Nonsteroidal Anti-Inflammatory Agents Analgesic Codrugs of Opioids and Cannabinoids Codrugs Containing Anti-HIV Drugs SOFT DRUGS Introduction Indications Design Considerations Case Study: The Discovery of Esmolol Summary PART FOUR: Preclinical and Clinical Considerations for Prodrugs PHARMACOKINETIC AND BIOPHARMACEUTICAL CONSIDERATIONS IN PRODRUG DISCOVERY AND DEVELOPMENT Introduction Understanding Pharmacokinetic/Pharmacodynamic Relationships Pharmacokinetics Tools for the Prodrug Scientist Enzymes Involved with Prodrug Conversion Use of the Caco-2 System for Permeability and Active Transport Evaluation XP13512: Improving PK Performance by Targeting Active Transport Prodrug Absorption: Transport/Metabolic Conversion Interplay Preabsorptive Degradation Biopharmaceutical-Based PK Modeling for Prodrug Design Conclusions THE IMPACT OF PHARMACOGENETICS ON THE CLINICAL OUTCOMES OF PRODRUGS Introduction Clopidogrel and CYP2C19 Codeine and CYP2D6 Tamoxifen and CYP2D6 Fluorouracil Prodrugs and Carboxylesterase Irinotecan and Carboxylesterase 2 Others Drug Development Implication Conclusions

Über den Autor

Jarkko Rautio is professor of pharmaceutical chemistry and head of the multidisciplinary Pharmaceutical and Medicinal Chemistry (PMC) research group at the School of Pharmacy, University of Eastern Finland (formerly University of Kuopio), where he received his PhD in pharmaceutical chemistry in 2000. He subsequently carried out his postdoctoral studies at the University of Maryland, Baltimore, USA, and was a visiting scientist at GlaxoSmithKline, North Carolina, while also co-founding the American Association of Pharmaceutical Scientists (AAPS) Prodrug Focus Group in 2005. Professor Rautio's research focuses on chemistry-based methods, especially prodrugs, to overcome the liabilities of drugs.


"The book captures all the important aspects of prodrugs. It is well organized in that each chapter presents a specific topic with very little duplication of contents between chapters ... Given the fact that prodrugs are now increasingly integrated into early drug discovery, this type of book would be a valuable addition to the library of any drug discovery institution." (Journal of Medicinal Chemistry, 8 August 2011) "Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development." (Pharmiweb, 16 February 2011)

ISBN 3-527-32603-0

ISBN 978-3-527-32603-7

Buch empfehlen Buch empfehlen
Sparen Sie Versandkosten beim Kauf weiterer Artikel dieses Buchhändlers.
Lettische Grammatik von Holst, Jan Henrik
29,90 EUR

Absence, enquête et quête dans le roman francophone von Tang, Alice Delphine (Herausgeber); Bissa Enama, Patricia (Herausgeber)
45,95 EUR
Meine zuletzt angesehenen antiquarischen und neue Bücher
Meine letzten Buch Suchanfragen
    Noch keine Suchanfragen vorhanden.

© 2003 - 2018 by whSoft GmbH
Entdecken Sie außerdem: Antiquariatsportal · Achtung-Bücher.de · Booklink · Buchhai - Bücher Preisvergleich
Alle genannten Preise sind Bruttopreise und enthalten, soweit nicht anders vom Verkäufer angegeben, die gesetzliche Umsatzsteuer.